Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
October is celebrated as breast cancer awareness month annually, and Hologic HOLX, this time too, honored the occasion by ringing the Nasdaq opening bell for the 18th consecutive time. While celebrating this yearly tradition, the company came into the limelight as it also introduced a comprehensive education campaign aimed at debunking common myths about breast cancer, mammograms and breast density.
Hologic (HOLX) closed at $80.26 in the latest trading session, marking a +0.48% move from the prior day.
Hologic (HOLX) reachead $79.77 at the closing of the latest trading day, reflecting a -0.98% change compared to its last close.
Steve MacMillan, Hologic chairman, president and CEO and Illumina chairman, joins 'Squawk Box' to discuss breast cancer awareness month, impact of AI on breast cancer detection, AI-powered diagnostics and the future of healthcare, and more.
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In Breast Health, Hologic expands its product offering from imaging to cover the continuum of breast cancer care, including biopsy and surgery.
Hologic's strength in Molecular Diagnostics is highly promising. Yet, macroeconomic uncertainties can pose headwinds for its operations.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
In the closing of the recent trading day, Hologic (HOLX) stood at $81.39, denoting a -1.23% change from the preceding trading day.
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.